[HTML][HTML] SARS-CoV-2 infection: a possible risk factor for incidence and recurrence of cancers

A Jafarzadeh, R Gosain, SMJ Mortazavi… - … -Oncology and Stem …, 2022 - ncbi.nlm.nih.gov
SARS-CoV-2-infected cancerous patients are unable to produce an effective anti-virus …
of SARS-CoV-2 infection on cancer development and recurrence, and the potential cancer

SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features?

GM Busetto, A Porreca, F Del Giudice, M Maggi… - Urologia …, 2020 - karger.com
… Tobacco smoking is considered a risk factor for bladder cancer recurrence and
progression. Smoking pattern, intensity and duration are responsible for poorer bladder …

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

G Mancebo, JM Solé-Sedeño, I Membrive… - … of Gynecologic Cancer, 2021 - ijgc.bmj.com
… . A national, prospective observational study of first recurrence after primary treatment for
gynecological cancer in Norway. Acta Obstet Gynecol Scand 2017;96:1162–9.doi:10.1111/aogs…

Infection and reinfection with SARSCoV‑2 in cancer patients: A cohort study

C Nitipir, AI Parosanu, M Olaru… - Experimental and …, 2022 - spandidos-publications.com
… in cancer patients with … cancers, pulmonary cancer patients had a particularly higher overall
mortality rate (6). Although the term reinfection is somewhat controversial, the recurrence of …

[HTML][HTML] Correlation of SARSCoV‑2 to cancer: Carcinogenic or anticancer?

YS Li, HC Ren, JH Cao - International journal of …, 2022 - spandidos-publications.com
… (NK cell) lymphoma and Hodgkin's lymphoma, while SARSCoV‑2 elicited anti‑tumor immune
… characteristics of SARSCoV‑2 as well as strategies to protect patients with cancer during …

[HTML][HTML] Commentary: SARS-CoV-2 vaccines and cancer patients

C Corti, G Curigliano - Annals of Oncology, 2021 - ncbi.nlm.nih.gov
… of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2
(SARS-Cov-2) … 1 Higher mortality of COVID-19 seems to be related to cancer, but data are …

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

O Ünsal, O Yazıcı, N Özdemir, E Cubukcu, B Ocak… - Future …, 2022 - Taylor & Francis
Introduction: The objective of this study was to evaluate the clinical and laboratory outcomes
of solid cancer patients who were reinfected with COVID-19. Methods: Patients who were …

[HTML][HTML] SARSCoV‐2 reinfection in a cancer patient with a defective neutralizing humoral response

C Borgogna, M De Andrea, G Griffante… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
SARSCoV‐2 infection. In the next few months, the patient did not show any respiratory
symptoms. However, the deterioration of his cancer … , causing concern for a recurrence of COVID‐…

A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations

SM Piri, M Edalatfar, S Shool, MN Jalalian… - Infectious …, 2021 - Taylor & Francis
… review to evaluate rate of SARS-CoV-2 recurrence, changes in disease … SARS-CoV-2 and
disease recurrence, disease and patients’ characteristics, risk factors for predicting recurrence

An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study

C Song, Z Dong, H Gong, XP Liu, X Dong… - Journal of Cancer …, 2021 - Springer
… to adjust their cancer management strategies as soon as possible to reduce the risk of
SARS-CoV-2 infection and tumor recurrence. However, data on cancer patients with SARS-CoV-2 …